Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Sarcoma 17Rhabdomyosarcoma 14Malignant mesenchymal tumor 7Neuroectodermal Tumors, Primitive, Peripheral 4Rhabdomyosarcoma, Embryonal 3Fibrosarcoma 3Sarcoma, Ewing 2Rhabdomyosarcoma, Alveolar 2Liposarcoma 2Hemangiosarcoma 2Hemangiopericytoma, Malignant 2Desmoplastic Small Round Cell Tumor 2Sarcoma, Alveolar Soft Part 1Ovarian Neoplasms 1Melanoma 1Histiocytoma, Malignant Fibrous 1Dermatofibrosarcoma 1Chondrosarcoma 1

Interventions

Cyclophosphamide 25Temozolomide 22Vincristine 18Irinotecan 18Doxorubicin 13Topotecan 10Melphalan 10Etoposide 10Ifosfamide 8Busulfan 8cabozantinib 7Magnetic Resonance Spectroscopy 7Granulocyte Colony-Stimulating Factor 7Filgrastim 6regorafenib 5fludarabine 5X-Rays 5Specimen Handling 5Sirolimus 5Radiotherapy 5Gemcitabine 5Drug Therapy 5pegfilgrastim 4palbociclib 4liposomal doxorubicin 4irinotecan sucrosofate 4ganitumab 4fludarabine phosphate 4Trabectedin 4Phantoms, Imaging 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Sarcoma, Ewing × Dactinomycin × Sarcoma × Clear all
NCT07194044 2026-05-15

METTSEO

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Recruiting
15 enrolled
Sarcoma

Sarcoma, Ewing

NCT02063022 2022-09-19

EW-1

Italian Sarcoma Group

Phase 3 Completed
278 enrolled
Sarcoma

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡